Abstract | AIMS: METHODS AND RESULTS: We found that CEBPD protein colocalized with macrophages in human and mouse (C57BL/6, Apoe-/-) atherosclerotic plaques and that Cebpd deficiency in bone marrow cells suppressed atherosclerotic lesions in hyperlipidemic Apoe-/- mice. CEBPD was responsive to modified low-density lipoprotein ( LDL) via the p38MAPK/CREB pathway, and it promoted lipid accumulation in M1 macrophages but not in M2 macrophages. CEBPD up-regulated pentraxin 3 (PTX3), which promoted the macropinocytosis of LDL, and down-regulated ATP-binding cassette subfamily A member 1 (ABCA1), which impaired the intracellular cholesterol efflux in M1 macrophages. We further found that simvastatin (a HMG-CoA reductase inhibitor) could target CEBPD to block lipid accumulation in a manner not directly related to its cholesterol-lowering effect in M1 macrophages. CONCLUSION: This study underscores how CEBPD functions at the junction of inflammation and lipid accumulation in M1 macrophages. Therefore, CEBPD-mediated lipid accumulation in M1 macrophages could represent a new therapeutic target for the treatment of cardiovascular diseases.
|
Authors | Hong-Yue Lai, Ling-Wei Hsu, Hsin-Hwa Tsai, Yu-Chih Lo, Shang-Hsun Yang, Ping-Yen Liu, Ju-Ming Wang |
Journal | Cardiovascular research
(Cardiovasc Res)
Vol. 113
Issue 11
Pg. 1376-1388
(Sep 01 2017)
ISSN: 1755-3245 [Electronic] England |
PMID | 28859294
(Publication Type: Journal Article)
|
Copyright | Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For permissions, please email: [email protected]. |
Chemical References |
- ATP Binding Cassette Transporter 1
- CEBPD protein, human
- Cebpd protein, mouse
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Lipoproteins, LDL
- CCAAT-Enhancer-Binding Protein-delta
- Cholesterol
|
Topics |
- ATP Binding Cassette Transporter 1
(genetics)
- Animals
- Atherosclerosis
(drug therapy, metabolism)
- CCAAT-Enhancer-Binding Protein-delta
(metabolism)
- Cholesterol
(metabolism)
- Foam Cells
(drug effects, metabolism)
- Homeostasis
(drug effects)
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(pharmacology)
- Hypercholesterolemia
(drug therapy, metabolism)
- Lipid Metabolism
- Lipoproteins, LDL
(metabolism)
- Macrophages
(drug effects, metabolism)
- Mice
- Mice, Inbred C57BL
- Up-Regulation
|